Clinical trial
6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee…
NCT00170872 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00170872 |
|---|---|
| Title | 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis |
| Official title | A 6 Week, Multicenter, Open-label Trial to Evaluate the Safety, Tolerability and Efficacy of Lumiracoxib 200mg o.d. in Patients With Primary Knee Osteoarthritis or Rheumatoid Arthritis |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis, Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Lumiracoxib |
| Enrollment | 135 |
| Start date | Nov 1, 2004 |
| Primary completion | Jul 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | May 21, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: